In partnership with
Oral selinexor+pomalidomide+dexamethasone offers hope for heavily pre-treated multiple myeloma
Rivaroxaban is safe and effective for paediatric venous thromboembolism
CAR T-cell therapy successful in older non-Hodgkin’s lymphoma patients
Mild renal impairment in African Americans does not affect OS in AML
20-year follow-up of imatinib in chronic myeloid leukaemia
Oral Azacitidine Improves Overall Survival in Patients with AML in Remission: a Promise for Maintenance Therapy?
Likely New Standard of Care: Blinatumomab for Children with Relapsed B-ALL
Pivotal Phase 3 Trial in Cold Agglutinin Disease
Dual-target CAR T therapy Yields 100% Response in R/R MM
BCL11A as Novel Target in Gene Therapy for Sickle Cell Disease
Top image: @ iStockPhoto: ustas7777777
The content and interpretation of these conference highlights are the views and comments of the speakers/ authors.
BACK TO TOP